Results 31 to 40 of about 1,862,216 (244)
Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost
SAGE Open Medical Case Reports, 2016 Stent fracture is a rare complication of drug-eluting stent implantation with a reported rate of 0.84%–3.2% in various clinical studies with first-generation drug-eluting stents and 29% in autopsy studies.
Alev Arat Ozkan +2 more
doaj +1 more source
Randomized Comparison of Sirolimus and Paclitaxel Drug-Eluting Stents for Long Lesions in the Left Anterior Descending Artery: an Intravascular Ultrasound Study [PDF]
, 2008 The objective of this prospective randomized study was to verify whether the superiority of the sirolimus-eluting stent (SES) in inhibiting neointimal hyperplasia could be demonstrated in complex coronary lesions. The SES was compared with the paclitaxel-
BRANCHITTA, GIULIA
core +1 more source
Paclitaxel Drug-eluting Tracheal Stent Could Reduce Granulation Tissue Formation in a Canine Model
Chinese Medical Journal, 2016 Background: Currently available silicone and metallic stents for tracheal stenosis are associated with many problems. Granulation proliferation is one of the main complications.
Ting Wang +5 more
doaj +1 more source
Drug-eluting stent in diabetes [PDF]
Sao Paulo Medical Journal, 2007 Long-term evaluation of cardiovascular risk among diabetic patients has shown that the incidence of death due to myocardial infarction among these patients is 20%, whereas among nondiabetic patients it is only 3.5%. Such observations haveled to classifying diabetes as a risk that is equivalent to establi shed coronary artery disease.
Lemos Júnior, Hernani Pinto de +2 more
openaire +4 more sources
Decision analytic models, sensitivity analysis and value of information in economic evaluations in health care [PDF]
, 2010 Economic evaluations of health care technologies are now commonly carried out to assess the economic value of new pharmaceuticals, medical devices and procedures.
Bischof, Matthias
core +1 more source
First clinical evidence characterizing safety and efficacy of the new CoCr Biolimus-A9 eluting stent: The Biomatrix Alpha™ registry [PDF]
, 2020 Background The biolimus-eluting stent (BES) was the first to elute anti-proliferative drug from a biodegradable polymer. In the randomized LEADERS trial, a stainless steel BES showed non-inferior efficacy compared to a sirolimus-eluting stent and a long ...
Mamas
core +1 more source
Journal of the Pakistan Medical AssociationObjective: To compare the efficacy of drug-eluting stents and drug-eluting balloons in treating in-stent restenosis. Method: The systematic review was conducted from January to February 2022, and comprised literature search on PubMed, ProQuest ...
Tinanda Tarigan +3 more
doaj +1 more source
Trials, 2012 Background Neointimal hyperplasia plays a pivotal role in the pathogenesis of in-stent restenosis in patients undergoing percutaneous coronary interventions.
Burzotta Francesco +10 more
doaj +1 more source
Frontiers in Pharmacology, 2020 Drug eluting ureteral stent is an effective means for local drug delivery to the urinary tract. It can potentially solve a variety of upper urinary tract problems, such as stent-related urinary tract infections and discomfort, ureteral stricture, and ...
Hongli Shan +6 more
doaj +1 more source
Anatolian Journal of Cardiology, 2023 Background: This study aimed to systematically review the evidence of drug-coated balloon used in the treatment of acute myocardial infarction and compared with using drug-eluting stent in terms of clinical and angiographic outcomes for a relatively long
Zhen Fang +4 more
doaj +1 more source